We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$98.6B
AUM Growth
+$9.82B
(+11%)
Cap. Flow
+$3.18B
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
34.51%
Holding
3,532
New
899
Increased
935
Reduced
953
Closed
698
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.93B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Cencora
COR
|
+$492M |
| 4 |
Netflix
NFLX
|
+$452M |
| 5 |
Bank of America
BAC
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$636M |
| 2 |
Eli Lilly
LLY
|
+$572M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$502M |
| 4 |
Advanced Micro Devices
AMD
|
+$395M |
| 5 |
CRH
CRH
|
+$379M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.19% |
| 2 | Consumer Discretionary | 12.64% |
| 3 | Healthcare | 9.35% |
| 4 | Financials | 8.34% |
| 5 | Communication Services | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MREO
1701
Mereo BioPharma
MREO
$49.4M
| $1.58M | ﹤0.01% |
767,744
| – | – |
|
1702
Stock Yards Bancorp
SYBT
$2.52B
| $1.57M | ﹤0.01% |
22,490
-3,655
| -14% | -$282K |
|
1703
Shattuck Labs
STTK
$651M
| $1.57M | ﹤0.01% |
+656,653
| New | +$803K |
|
1704
Concentrix
CNXC
$1.55B
| $1.57M | ﹤0.01% |
33,961
-216,032
| -86% | -$11.5M |
|
|
ARX
1705
Accelerant Holdings
ARX
$3.21B
| $1.57M | ﹤0.01% |
+105,215
| New | +$2.46M |
|
1706
Prairie Operating Co
PROP
$66.5M
| $1.57M | ﹤0.01% |
786,645
+499,859
| +174% | +$1.42M |
|
1707
Byline Bancorp
BY
$1.78B
| $1.56M | ﹤0.01% |
56,329
+9,580
| +20% | +$267K |
|
1708
Taysha Gene Therapies
TSHA
$1.57B
| $1.56M | ﹤0.01% |
476,865
+397,367
| +500% | +$1.13M |
|
|
1709
CALL
Netflix
NFLX
$301B
| $1.56M | ﹤0.01% |
+13,000
| New | +$1.59M |
|
|
BRSL
1710
Brightstar Lottery PLC
BRSL
$1.92B
| $1.55M | ﹤0.01% |
+90,033
| New | +$1.44M |
|
1711
CGI
GIB
$15B
| $1.55M | ﹤0.01% |
+17,403
| New | +$1.68M |
|
1712
Freshpet
FRPT
$3.01B
| $1.55M | ﹤0.01% |
28,093
-219,336
| -89% | -$13.6M |
|
1713
Applied Optoelectronics
AAOI
$7.07B
| $1.54M | ﹤0.01% |
+59,564
| New | +$1.52M |
|
|
INR
1714
Infinity Natural Resources
INR
$234M
| $1.54M | ﹤0.01% |
117,638
-7,986
| -6% | -$114K |
|
1715
iShares US Medical Devices ETF
IHI
$3.14B
| $1.54M | ﹤0.01% |
25,552
+688
| +3% | +$42.1K |
|
1716
Paymentus
PAY
$4.29B
| $1.53M | ﹤0.01% |
50,157
-258,437
| -84% | -$8.54M |
|
1717
Royal Bank of Canada
RY
$295B
| $1.53M | ﹤0.01% |
+10,400
| New | +$1.43M |
|
1718
American Homes 4 Rent
AMH
$12.2B
| $1.53M | ﹤0.01% |
46,071
-277,372
| -86% | -$9.67M |
|
1719
BrightView Holdings
BV
$1.3B
| $1.53M | ﹤0.01% |
114,162
-393,246
| -78% | -$5.84M |
|
1720
ORIX
IX
$42.8B
| $1.53M | ﹤0.01% |
58,493
+26,870
| +85% | +$666K |
|
|
APLT
1721
DELISTED
Applied Therapeutics
APLT
| $1.53M | ﹤0.01% |
2,542,688
+998,497
| +65% | +$470K |
|
1722
Liquidity Services
LQDT
$1.23B
| $1.52M | ﹤0.01% |
55,453
-126,082
| -69% | -$3.24M |
|
1723
Genesco
GCO
$432M
| $1.52M | ﹤0.01% |
+52,404
| New | +$1.44M |
|
1724
Rexford Industrial Realty
REXR
$8.64B
| $1.52M | ﹤0.01% |
+36,917
| New | +$1.45M |
|
1725
Allison Transmission
ALSN
$10B
| $1.52M | ﹤0.01% |
17,853
-46,481
| -72% | -$4.14M |
|
Similar funds
Marshall Wace's Q3 2025 Portfolio in Review
As of Q3 2025, Marshall Wace held 3,532 positions worth $98.6B, up 11% from $88.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $3.18B of net new capital in Q3 2025, opening 899 new positions and adding to 935 existing holdings. Its largest new stake was Texas Instruments: 1,537,539 shares worth $282M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $636M trimmed.
- Marshall Wace's largest Q3 2025 buy was Texas Instruments: 1,537,539 shares worth $282M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $3.93B increase.
- Marshall Wace's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $636M.
- Marshall Wace fully exited AT&T in Q3 2025, selling an estimated $235M.
- Marshall Wace's ten largest holdings make up 35% of its $98.6B portfolio in Q3 2025.
- Marshall Wace opened 899 new positions and closed 698 in Q3 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $98.6B.
Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.